tiprankstipranks
Trending News
More News >
Cathie Wood’s ARK Investment buys 262K shares of Crispr Therapeutics today
PremiumThe FlyCathie Wood’s ARK Investment buys 262K shares of Crispr Therapeutics today
11d ago
Crispr Therapeutics AG: Promising Partnership with Sirius Therapeutics Amidst Clinical and Market Uncertainties Warrants Hold Rating
Premium
Ratings
Crispr Therapeutics AG: Promising Partnership with Sirius Therapeutics Amidst Clinical and Market Uncertainties Warrants Hold Rating
18d ago
Crispr Therapeutics call volume above normal and directionally bullish
Premium
The Fly
Crispr Therapeutics call volume above normal and directionally bullish
19d ago
CRISPR Therapeutics Reports Q1 2025 Progress and Financials
PremiumCompany AnnouncementsCRISPR Therapeutics Reports Q1 2025 Progress and Financials
1M ago
Cathie Wood’s ARK Investment buys 329K shares of Crispr Therapeutics today
Premium
The Fly
Cathie Wood’s ARK Investment buys 329K shares of Crispr Therapeutics today
1M ago
Crispr Therapeutics price target lowered to $79 from $80 at BofA
Premium
The Fly
Crispr Therapeutics price target lowered to $79 from $80 at BofA
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100